Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1

Substance-Related Disorders Clinical Trial

Official title:

Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00033020
• Other study ID #: NIDA-CTN-0007-1
• Status: Completed
• Phase: Phase 3
• First received: April 5, 2002
• Last updated: January 11, 2017
• Start date: April 2001
• Est. completion date: February 2003

Study information

• Verified date: April 2010
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

Description:

The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics. The study will determine if motivational incentives along with standard care therapy is more effective than standard therapy alone for the treatment of patients using cocaine or methamphetamine and entering a substance abuse treatment program.

Other known NCT identifiers

• NCT00015418

Recruitment information / eligibility

• Status: Completed
• Enrollment: 390
• Est. completion date: February 2003
• Est. primary completion date: February 2003
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

1. Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry

2. Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment

Exclusion Criteria:

1. Unable to give informed consent (fails simple consent quiz)

2. Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?

Study Design

Allocation: Randomized, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Substance-Related Disorders

Intervention

Behavioral:
• Behavior Therapy

Locations

Country	Name	City	State
United States	Aegis Medical Systems, Inc.	Bakersfield	California
United States	Glenwood Life Counseling Center	Baltimore	Maryland
United States	Charleston Center	Charleston	South Carolina
United States	Greenwich House, Inc.	New York	New York
United States	Lower Eastside Service Center (LESC)	New York	New York
United States	ACT	Philadelphia	Pennsylvania
United States	Oasis Clinic	Washington	District of Columbia

Sponsors (1)

Lead Sponsor	Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ASI
Primary	Opioid and cocaine use
Primary	AIDS risk behavior

External Links

•   Data Elements